Treatment in Thailand costs from AUD $63,882 / ฿A2,171,973 to AUD $92,273 / ฿A3,137,294. Total costs depend on the required chemotherapy cycles, surgical complexity, and radiotherapy techniques. Australians save around 89% compared to local private fees, which average AUD $681,403 / ฿A23,167,712. Inclusions typically cover consultations, diagnostic imaging, hospital stays, and oncological medical supervision in hubs like Bangkok.
Bookimed Expert Insight: Bangkok clinics offer significant value for complex pediatric oncology. Bumrungrad International Hospital is accredited by Joint Commission International (JCI). It is ranked among the world's best hospitals by Newsweek. This ensures quality systems are independently verified. Specialized doctors like Dr. Nichakorn Seehirunwong use advanced imaging to guide treatment. Centralizing care in Bangkok provides access to over 1,300 specialists in one location.
| Thailand | Turkey | ||
| Complex treatment of neuroblastoma | from AUD $63,882 / ฿A2,171,973 | from AUD $39,749 / ฿A1,351,450 | from AUD $34,780 / ฿A1,182,519 |
No hidden fees – just official clinic prices. Pay at the clinic for Complex treatment of neuroblastoma upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Complex treatment of neuroblastoma and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Complex treatment of neuroblastoma journey.
The 5-year survival rate for high-risk neuroblastoma in Thailand ranges from 45% to 52%. Children receiving maintenance therapy with isotretinoin for 12 months show improved outcomes. In these cases, survival reaches 60.4%. Facilities like Bumrungrad International Hospital maintain international standards through JCI accreditation and Newsweek rankings.
Bookimed Expert Insight: While university hospitals offer the strongest data, private JCI-accredited hubs like Bumrungrad International Hospital serve 50% international patients. Their high patient volume and Newsweek-recognised technology provide a reliable alternative for complex paediatric oncology. This is particularly relevant for Australians seeking private care without long waits.
Complex neuroblastoma treatment in Thailand uses a multimodality protocol. This combines intensive chemotherapy, surgical resection, and consolidation therapies like stem cell transplants. Specialist centres in Bangkok use Thai Pediatric Oncology Group standards to manage high-risk cases. They follow induction, consolidation, and maintenance phases.
Bookimed Expert Insight: Australian treatment often includes expensive anti-GD2 immunotherapy. Thai protocols achieve high efficacy by intensifying high-dose chemotherapy and MIBG therapy instead. These multimodality programmes in Bangkok cost from $45,000 to $65,000. This offers significant savings compared to the $480,000 average in Australia.
Patient Consensus: International families note the seamless transition between surgical and oncology teams in Thailand. The availability of 131I-MIBG therapy alongside transplants is highly valued for tackling aggressive cases.
Immunotherapy for neuroblastoma is available in Thailand through private centres like Bumrungrad International Hospital. These JCI-accredited facilities provide targeted therapies like monoclonal antibodies. Complex neuroblastoma treatment in Thailand costs from $45,000 to $65,000.
Bookimed Expert Insight: Immunotherapy is accessible in Bangkok. Savings are most significant when bundling it with intensive consolidation phases. Bumrungrad International Hospital combines Newsweek-ranked oncology expertise with high-volume experience. This allows for smoother coordination when sourcing specialised biologics that require strict cold-chain logistics.
Patient Consensus: Families find private paediatric intensive care support in Thailand provides vital reassurance during complex treatments. Confirming drug availability and trial eligibility with Bangkok specialists helps avoid local logistical delays.